Activation of the Receptor NKG2D Leads to Production of Th17 Cytokines in CD4+ T Cells of Patients With Crohn's Disease
- 1 July 2011
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 141 (1) , 217-226.e2
Abstract
No abstract availableKeywords
Funding Information
- Institut National de la Santé et de la Recherche Médicale
- Novo Nordisk
This publication has 30 references indexed in Scilit:
- Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environmentProceedings of the National Academy of Sciences, 2010
- Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4 + T CellsScience, 2010
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2009
- Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's diseaseJournal of Experimental Medicine, 2009
- Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammationJournal of Experimental Medicine, 2009
- Blockade of NKG2D signaling prevents the development of murine CD4+T cell-mediated colitisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Phenotypic and functional features of human Th17 cellsJournal of Experimental Medicine, 2007
- Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptidesJournal of Experimental Medicine, 2006
- Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's diseaseThe Lancet, 2005
- The immunological and genetic basis of inflammatory bowel diseaseNature Reviews Immunology, 2003